Whereas the involvement of NFκB activation in hematologic malignancies has been well established, identifying a role for NFκB in solid tumors required the use of mouse models in which tumor induction depends on inflammation, thus mimicking inflammation-driven cancers in humans [13]. The gene discussed is NFKB1; the disease is neoplasm.